105.27
price up icon2.57%   2.64
pre-market  Pre-mercato:  102.44   -2.83   -2.69%
loading
Precedente Chiudi:
$102.63
Aprire:
$103.43
Volume 24 ore:
7.50M
Relative Volume:
1.68
Capitalizzazione di mercato:
$465.74B
Reddito:
$39.36B
Utile/perdita netta:
$13.79B
Rapporto P/E:
43.72
EPS:
2.4077
Flusso di cassa netto:
$9.83B
1 W Prestazione:
-1.53%
1M Prestazione:
-10.86%
6M Prestazione:
-20.80%
1 anno Prestazione:
+1.62%
Intervallo 1D:
Value
$103.00
$105.74
Intervallo di 1 settimana:
Value
$99.42
$107.00
Portata 52W:
Value
$94.73
$148.15

Novo Nordisk Adr Stock (NVO) Company Profile

Name
Nome
Novo Nordisk Adr
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
72,000
Name
Cinguettio
@novonordisk
Name
Prossima data di guadagno
2024-12-06
Name
Ultimi documenti SEC
Name
NVO's Discussions on Twitter

Confronta NVO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
NVO 105.27 465.74B 39.36B 13.79B 9.83B 2.4077
LLY 753.41 693.54B 40.86B 8.37B -2.28B 5.4193
JNJ 153.11 353.35B 87.70B 14.68B 19.03B 13.47
ABBV 167.76 294.70B 55.53B 5.12B 15.62B 3.65
MRK 97.44 248.54B 63.17B 12.15B 14.84B 1.80

Novo Nordisk Adr Stock (NVO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-05-30 Iniziato Goldman Buy
2024-04-12 Iniziato BMO Capital Markets Outperform
2024-01-23 Iniziato Morgan Stanley Overweight
2024-01-16 Ripresa UBS Neutral
2023-12-01 Iniziato Cantor Fitzgerald Overweight
2023-10-02 Iniziato Argus Buy
2023-07-14 Iniziato HSBC Securities Buy
2022-07-15 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2022-06-28 Downgrade UBS Neutral → Sell
2022-06-27 Aggiornamento Exane BNP Paribas Underperform → Neutral
2022-06-07 Aggiornamento JP Morgan Neutral → Overweight
2022-05-31 Aggiornamento Guggenheim Neutral → Buy
2022-04-25 Aggiornamento Cowen Market Perform → Outperform
2022-04-12 Aggiornamento Morgan Stanley Underweight → Equal-Weight
2022-03-16 Aggiornamento Deutsche Bank Hold → Buy
2022-01-25 Downgrade Liberum Hold → Sell
2021-12-20 Downgrade JP Morgan Overweight → Neutral
2021-12-17 Downgrade Deutsche Bank Buy → Hold
2021-01-20 Downgrade Credit Suisse Outperform → Neutral
2021-01-15 Iniziato Deutsche Bank Buy
2020-09-29 Iniziato Berenberg Hold
2020-07-06 Downgrade BofA Securities Buy → Neutral
2020-05-11 Downgrade UBS Buy → Neutral
2020-05-04 Iniziato Cowen Market Perform
2020-03-16 Aggiornamento BofA/Merrill Neutral → Buy
2020-01-03 Downgrade Guggenheim Buy → Neutral
2019-11-18 Aggiornamento Barclays Equal Weight → Overweight
2019-09-17 Aggiornamento Citigroup Neutral → Buy
2019-08-30 Downgrade Jefferies Hold → Underperform
2019-06-20 Downgrade Deutsche Bank Buy → Hold
2019-06-11 Aggiornamento Barclays Underweight → Equal Weight
2019-04-29 Aggiornamento Credit Suisse Neutral → Outperform
2019-01-29 Iniziato Exane BNP Paribas Outperform
2018-12-11 Ripresa Jefferies Hold
2018-10-09 Iniziato Guggenheim Buy
2017-12-29 Aggiornamento JP Morgan Underweight → Neutral
2017-12-06 Aggiornamento BofA/Merrill Neutral → Buy
2017-12-01 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2017-09-25 Downgrade Exane BNP Paribas Outperform → Neutral
2017-09-06 Aggiornamento BofA/Merrill Underperform → Neutral
Mostra tutto

Novo Nordisk Adr Borsa (NVO) Ultime notizie

pulisher
Nov 20, 2024

Novo Nordisk ADR (NYSE: NVO) Could Fell Another -55.9% - Stocks Register

Nov 20, 2024
pulisher
Nov 20, 2024

Inside the Market Dominance of the Top 10 Pharma Giants - Value the Markets

Nov 20, 2024
pulisher
Nov 20, 2024

Is Novo Nordisk Stock a Buy Right Now? - The Motley Fool

Nov 20, 2024
pulisher
Nov 08, 2024

Biopharma Stock Election Impact: Potential Reduced IRA Headwind but Unpredictable Challenges - Morningstar

Nov 08, 2024
pulisher
Nov 06, 2024

Novo Nordisk A/S (NVO) Stock Price, News, Quote & History - Yahoo Finance

Nov 06, 2024
pulisher
Nov 06, 2024

NVO Misses Q3 Earnings & Revenue Estimates, Updates 2024 View - Yahoo Finance

Nov 06, 2024
pulisher
Nov 06, 2024

European Equities Traded in the US as American Depositary Receipts Kick Off Week Lower in Monday Trading - MSN

Nov 06, 2024
pulisher
Nov 06, 2024

Novo Nordisk ADR earnings beat by $5.24, revenue topped estimates - Investing.com Australia

Nov 06, 2024
pulisher
Oct 21, 2024

European Equities Traded in the US as American Depositary Receipts Open Week Slightly Higher - MSN

Oct 21, 2024
pulisher
Oct 21, 2024

India Subcutaneous Drug Delivery Devices Market Size & Outlook, 2030 - Grand View Research

Oct 21, 2024
pulisher
Oct 18, 2024

Why this money manager sees FirstService, Novo Nordisk and Microsoft as good long-term holdings - The Globe and Mail

Oct 18, 2024
pulisher
Oct 16, 2024

NVO: 3 European Stocks to Buy as the Region Recovers - StockNews.com

Oct 16, 2024
pulisher
Oct 11, 2024

NVO’s price-to-cash ratio: How it affects the stock’s valuation. - US Post News

Oct 11, 2024
pulisher
Oct 09, 2024

Market cap of Novo Nordisk ADR [NVO] reaches 391.26B – now what? - The DBT News

Oct 09, 2024
pulisher
Oct 09, 2024

Analyzing Novo Nordisk ADR (NVO) After Recent Trading Activity - Knox Daily

Oct 09, 2024
pulisher
Oct 09, 2024

Monitoring Melco Resorts & Entertainment Ltd ADR (MLCO) after recent insider movements - Knox Daily

Oct 09, 2024
pulisher
Oct 07, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Oct 07, 2024
pulisher
Oct 07, 2024

Precidian to List First ADRhedged Securities in the U.S. on Cboe - Traders Magazine

Oct 07, 2024
pulisher
Oct 03, 2024

Novo Nordisk Currently Down Six Consecutive Days, on Pace for Longest Losing Streak Since September 2022 — Data Talk - Morningstar

Oct 03, 2024
pulisher
Oct 02, 2024

Novo Nordisk ADR (NVO) receives a Buy rating from Goldman - Knox Daily

Oct 02, 2024
pulisher
Oct 02, 2024

The Attractiveness of Investing In Tenaris S.A. ADR (TS) is Growing - Knox Daily

Oct 02, 2024
pulisher
Oct 02, 2024

Stock Market Recap: Novo Nordisk ADR (NVO) Concludes at 118.01, a -0.89 Surge/Decline - The Dwinnex

Oct 02, 2024
pulisher
Oct 02, 2024

Banco Santander S.A. ADR [SAN] Investment Appeal on the Rise - Knox Daily

Oct 02, 2024
pulisher
Oct 02, 2024

Analyzing Indonesia Energy Corp Ltd (INDO) After Recent Trading Activity - Knox Daily

Oct 02, 2024

Novo Nordisk Adr Azioni (NVO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
drug_manufacturers_general JNJ
$153.11
price up icon 0.07%
$167.76
price up icon 0.71%
drug_manufacturers_general MRK
$97.44
price up icon 0.93%
drug_manufacturers_general LLY
$753.41
price up icon 3.25%
drug_manufacturers_general NVS
$103.09
price down icon 0.17%
Capitalizzazione:     |  Volume (24 ore):